The rally in shares in Moderna Inc. jumped through news late Tuesday that the U.S. government ordered 100 million doses of its COVID-19 vaccine candidate on Wednesday as analysts waited for what the order meant for prices. Modern MRNA, + 1.94% is widely regarded as a front-runner in the race …
Read More »
Gold futures fell sharply on Tuesday, bringing bullion on course for its steepest daily slide in nearly five months, as global equities were buoyed by hopes of a coronavirus vaccine being approved by Russia, though that approval was met with some skepticism by experts. However, Dr Anthony Fauci, director of …
Read More »
Text size fake pictures Shares of AstraZeneca rose on Thursday as new drug sales helped the British pharmaceutical giant exceed expectations in the second quarter. Late-stage trials for its experimental coronavirus vaccine, developed with the University of Oxford, have also begun in the UK, Brazil and South Africa, the company …
Read More »
Text size Johnson & Johnson became the third western biopharmaceutical company to start a new test of its Covid-19 vaccine this week, but with one difference: in a surprise announcement Thursday morning, the company said it would test its vaccine in a format single dose. Moderna (MRNA) and Pfizer (PFE) …
Read More »
Text size Photograph by JOSEPH PREZIOSO / AFP via Getty Images The Modern biotechnology company, which has received commitments of nearly $ 1 billion from the federal government to develop its Covid-19 vaccine, seeks to sell the vaccine for between $ 25 and $ 30 per dose, the Financial Times …
Read More »